A critical breakthrough in cancer research is arising with the use of VHH fragments to reactivate damaged p53. This vital cancer inhibitor protein is frequently disabled in many types of tumors, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research